The NILVAD Group
The NILVAD consortium consists of 17 participating institutions based in ten different EU member states as well as one partner in the USA. It will mobilize the synergies of the major relevant European research groups to conduct a clinical trial on the efficacy of nilvadipine in Alzheimer's disease. The NILVAD consortium is formed by renowned researchers from all over Europe and USA, each one with a strong scientific and/or clinical background in the fields of Alzheimer's disease and dementia. Excellent research standards - including the latest scientific and technological advances - will be the basis for the NILVAD Project.